By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NanoString Technologies Inc. 

201 Elliott Avenue West
Suite 300
Seattle  Washington  98119  U.S.A.
Phone: 206-378-NANO Fax: 206-378-6288



Company News
NanoString (NSTG) To Present At The Canaccord Genuity Growth Conference 7/31/2015 7:31:48 AM
NanoString (NSTG) CEO On How Creating A Niche Is Good For Business: Q&A 7/23/2015 7:30:08 AM
NanoString (NSTG) To Release Second Quarter 2015 Financial Results And Host Conference Call On Tuesday, August 4, 2015 7/22/2015 7:42:26 AM
NanoString (NSTG) Release: NCCN Clinical Practice Guidelines For Breast Cancer Acknowledge Prosigna/PAM50 As Clinically Validated For Prediction Of Prognosis 7/17/2015 8:15:31 AM
NanoString (NSTG) Launches New Ncounter SPRINT Profiler Designed To Meet Needs Of The Individual Researcher 7/16/2015 7:57:02 AM
NanoString (NSTG) Names Alessandra Cesano, M.D., Ph.D. As Chief Medical Officer 7/9/2015 7:27:51 AM
NanoString (NSTG) Announces Publication Of Clinical Study Demonstrating The Ability Of Its Prosigna Breast Cancer Assay To Predict Response To Chemotherapy 7/8/2015 7:14:13 AM
ASCO15: NanoString (NSTG) Highlights Results From Three Significant New Prosigna Studies Presented At The 51st Annual Meeting Of The ASCO 6/1/2015 3:11:26 PM
Merck & Co. (MRK) And NanoString (NSTG) Announce Clinical Research Collaboration To Develop An Immune-Related Gene Expression Assay For Use In The Development Program For KEYTRUDA (Pembrolizumab) 5/28/2015 9:43:15 AM
Four Seattle Biotech Firms Looking to Hire Hundreds of New Employees 5/21/2015 6:31:28 AM